Bonus BioGroup Ltd. (BONS)
TASE
Closed
Aug 24, 2026
Day's Range
19.0052 wk Range
17.70Overview - BONS - Bonus BioGroup Ltd.
Key Statistics
Valuation
Enterprise Value
21.26B
EV / EBITDA
‪-9.95‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-76.44%‬
Return on Equity
‪-3,788.09%‬
Ownership
Shares Outstanding
1.16B
Float
638.16M
Held by Insiders
‪45.04%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.88‬
50-Day Avg
‪28.05‬
200-Day Avg
‪35.57‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BONS - Bonus BioGroup Ltd.
Peers - BONS - Bonus BioGroup Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TASE.
- BONSTASEBonus BioGroup Ltd.21.25BMarket Cap-22.84%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- AURATASEAura Investments Ltd.439.52BMarket Cap-36.33%52-week change18.45P/E (Trailing)‪12.50%‬Profit Margin
- ATRYTASEAtreyu Capital Markets Ltd.90.59BMarket Cap-28.39%52-week change7.97P/E (Trailing)‪96.43%‬Profit Margin
- BLRXTASEBioLineRx Ltd.4.17BMarket Cap-46.67%52-week change—P/E (Trailing)‪80.50%‬Profit Margin
- BOLTTASEBiolight Life Sciences Ltd.2.36BMarket Cap-92.63%52-week change-134.34P/E (Trailing)‪0.00%‬Profit Margin
- BIOVTASEBio View Ltd.1.16BMarket Cap-169.82%52-week change28.00P/E (Trailing)‪-76.92%‬Profit Margin
Profile Summary - BONS - Bonus BioGroup Ltd.
About
Bonus BioGroup Ltd. is an innovative biotechnology firm at the forefront of regenerative medicine. Primarily focused on the research and development of tissue engineering solutions, it aims to transform how various medical conditions are treated by developing personalized tissue implants. The company's flagship…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
